Tag Archives: latest

EU trachea transplant clinical trial TETRA “uncertain to take place”

The scandal of regenerative medicine surgeon Paolo Macchiarini and his deadly plastic tracheas made world news. Yet this human abuse, which started at the Karolinska Institutet in Sweden, was just a part of a much bigger horror story. The suffering and deaths of other trachea transplant patients of Macchiarini and his collaborators, those who received a decellurised cadaveric trachea, is much less known. I focused my reporting on it, bringing back to memory all those dead patients which the hospitals in London, Florence and Barcelona pretend never existed. Presently, 62 patients were scheduled to be treated with decellurised cadaveric trachea in two phase 1 clinical trials in UK and one EU-funded phase 2 clinical trial, all led by former Macchiarini partner, UCL laryngologist Martin Birchall. But now, all 3 clinical trials are not going anywhere. Read more [...]

A new era for EuroScientist to adapt to financial constraints

EuroScientist editor has left and this is an occasion for the magazine to make some changes and reinvent itself. While we will not change the goals and the mission of EuroScientist we will focus in the coming months on anticipating the debates at ESOF and debates on FP9. In addition, we will merge the EuroScience Newsletter into EuroScientist. Homo Scientificus Europaeus (HSE) will also be integrated in EuroScientist website in the following weeks. We will also invite new contributions from you whatever you think is useful and valuable for the discussions in the wider science community and beyond that among stakeholders in science and innovation. Read more [...]

Medicamentalia Contraceptives

Medicamentalia-Contraceptives is an international journalistic investigation by Civio on birth control access and barriers. We have combined data journalism with on-the-ground reporting to tell the stories of the women behind the statistics, to gather their opinions about birth control access and their freedom to decide about their bodies. This instalment follows in the footsteps of two predecessors, focused on access to essential medicines and access to vaccines around the world. Read more [...]